Daejeon, South Korea

Deog-Young Choi

This inventor holds 1 USPTO granted patent. Top assignees: Lg Life Sciences, Limited, Yamanouchi Pharmaceutical Company Ltd.. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deog-Young Choi. Retrieved from https://idiyas.com/inventor/deog-young-choi-guyxigyz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Deog-Young Choi: Innovator in Melanocortin Receptor Agonists

Introduction

Deog-Young Choi is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmacology, particularly through his work on melanocortin receptor agonists. His innovative approach has led to the development of compounds that have potential therapeutic applications.

Latest Patents

Deog-Young Choi holds a patent for "Melanocortin receptor agonists." This invention relates to a compound of formula 1, along with its pharmaceutically acceptable salt, hydrate, solvate, or isomer. The compound is effective as an agonist of the melanocortin receptor, and it includes an agonistic composition of the melanocortin receptor comprising the same as an active ingredient.

Career Highlights

Throughout his career, Deog-Young Choi has worked with prominent companies in the pharmaceutical industry. He has been associated with LG Life Sciences, Limited and Yamanouchi Pharmaceutical Company Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Deog-Young Choi has collaborated with several professionals in his field. Notable coworkers include Koo Lee and Heui-Sul Park, who have contributed to his research and development efforts.

Conclusion

Deog-Young Choi's work in the area of melanocortin receptor agonists showcases his innovative spirit and dedication to advancing pharmacological science. His contributions are significant in the ongoing quest for effective therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…